This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
We sincerely hope to see you at this year’s AABB Annual Meeting in San Antonio, TX on October ...
On August 9, 2019, the new CTS Laboratory Information System was successfully implemented in St...
An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...
Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...